The global biobanking market size was valued at USD 59.98 billion in 2025 and is projected to grow from USD 64.37 billion in 2026 to USD 113.27 billion by 2034, registering a CAGR of 7.32% during the forecast period from 2026 to 2034. Europe dominated the biobanking market with a market share of 36.4% in 2025.
Biobanking refers to the collection, processing, storage, and management of biological samples such as blood, tissues, DNA, and cells for research, clinical, and therapeutic applications. These repositories play a vital role in advancing precision medicine, drug discovery, regenerative medicine, and disease research by providing high-quality biological specimens and associated data.
The biobanking market demand is increasing due to the growing focus on personalized medicine, genomic research, and the rising prevalence of chronic diseases. Expanding clinical trials, increasing investments in life sciences research, and advancements in sample preservation technologies are supporting market growth. Additionally, the growing adoption of digital biobanking solutions and collaborative research initiatives is further driving industry expansion.
Download a Free Sample To learn more about this report,
Growing Adoption of Automated and Digitally Connected Biobanking Systems
The biobanking market trends are being driven by increasing demand for high-quality biological samples in drug discovery, precision medicine, genomics, and disease research. Biobanks are storing blood, tissue, DNA, RNA, and other biological specimens under controlled conditions to support research and the development of personalized treatments. Research institutions and pharmaceutical companies are increasingly adopting automated sample handling, robotic storage systems, barcode tracking, and laboratory information management systems to improve sample quality, traceability, and retrieval. The growing use of genomic sequencing and biomarker research is also increasing the need for well-characterized biological samples linked with clinical information. In addition, cloud-based data management and artificial intelligence (AI) are helping researchers organize large biobank datasets and identify useful relationships between samples, diseases, and genetic characteristics. Investments in population-scale biobanks are further strengthening research capabilities in cancer, rare diseases, infectious diseases, and chronic conditions.
These developments indicate that automated sample management, genomic research, digital data platforms, and population-scale biological collections will remain the key biobanking market trends, improving sample quality, supporting precision medicine, and driving long-term growth across biomedical research and healthcare.
Growing Demand for Biological Sample Storage and Increasing Biomedical Research
The biobanking market is expanding due to the increasing demand for the collection, processing, storage, and management of biological samples for biomedical research and clinical applications. Biobanks provide researchers with access to blood, tissue, DNA, RNA, and other biological specimens that support drug discovery, genomics, precision medicine, and disease research. Rising investments in biotechnology and pharmaceutical research, increasing prevalence of chronic diseases, and growing adoption of personalized medicine are further accelerating demand. These developments are significantly contributing to biobanking market growth as research organizations and healthcare institutions expand their biological sample repositories.
High Infrastructure Costs and Complex Sample Management Requirements
The biobanking market faces challenges due to the high cost of specialized storage infrastructure, advanced monitoring systems, and long-term sample preservation. Biobanks require controlled environments, reliable temperature management, backup power systems, and strict quality control procedures to maintain sample integrity. In addition, managing large volumes of biological specimens while maintaining accurate documentation and traceability can increase operational complexity. Recent biobanking market analysis indicates that these factors can restrict adoption, particularly among smaller research institutions and organizations with limited funding.
Expansion of Precision Medicine and Automated Biobank Technologies
The biobanking market is expected to benefit from increasing adoption of precision medicine, genomics, and advanced automated sample management technologies. Growing demand for high-quality biological specimens is encouraging pharmaceutical companies and research organizations to establish specialized biobanks for cancer research, genetic disorders, and drug development. Automation, artificial intelligence, digital sample tracking, and cloud-based data management are also creating significant growth opportunities. These developments are expected to strengthen the biobanking market size by improving sample accessibility, preservation, and research efficiency.
Maintaining Sample Integrity, Data Security, and Regulatory Compliance
The biobanking market continues to face challenges related to maintaining biological sample integrity, ensuring accurate sample traceability, protecting sensitive health data, and complying with evolving ethical and regulatory requirements. Biobanks must maintain strict temperature controls and standardized collection and preservation procedures to prevent sample degradation. Data associated with biological specimens must also be securely managed while ensuring appropriate consent and privacy protections. According to recent biobanking market reports, companies and research institutions are investing in automated monitoring, advanced laboratory information systems, cybersecurity technologies, and standardized biobanking protocols to improve sample quality and strengthen long-term operational reliability.
Services Segment is Projected to Register the Fastest Growth at a CAGR of 8.41%
The services segment is projected to register the fastest growth at a CAGR of 8.41% during 2026–2034. In 2025, the segment accounted for 38.2% of the global biobanking market, with a value of USD 34.51 billion. Growth is driven by increasing demand for specialized biobanking operations, laboratory processing, repository management, validation services, and cold chain logistics. Growing complexity in biospecimen management and expanding research activities continue to support the segment's growth.
The product segment dominated the market with a 61.8% share and a value of USD 55.83 billion. Its leading position is supported by strong demand for biobanking equipment, consumables, and laboratory information management systems required for efficient collection, storage, monitoring, and management of biological samples.
Request Customizationto receive a tailored report.
Laboratory Information Management Systems Segment is Projected to Register the Fastest Growth at a CAGR of 8.92%
The laboratory information management systems segment is projected to register the fastest growth at a CAGR of 8.92% during 2026–2034. In 2025, the segment accounted for 17.8% of the product segment, with a value of USD 16.08 billion. Growth is driven by increasing digitalization of biobanking operations, growing demand for efficient sample tracking, data management, and workflow automation, and the need to improve the accuracy and accessibility of biospecimen information.
Biobanking equipment dominated the product segment with a 48.7% share and a value of USD 44.00 billion. Biobanking consumables accounted for 33.5%, with a value of USD 30.26 billion. Increasing demand for reliable storage infrastructure, sample handling products, and laboratory supplies continues to support these segments.
Alarms & Monitoring Systems Segment is Projected to Register the Fastest Growth at a CAGR of 8.36%
The alarms & monitoring systems segment is projected to register the fastest growth at a CAGR of 8.36% during 2026–2034. In 2025, the segment accounted for 14.2% of the biobanking equipment segment, with a value of USD 12.83 billion. Growth is driven by increasing requirements for continuous monitoring of storage conditions, growing emphasis on biospecimen safety, and the need for rapid detection of temperature and equipment deviations.
Temperature control systems dominated the biobanking equipment segment with a 54.6% share and a value of USD 49.33 billion. Incubators & centrifuges accounted for 19.4%, while alarms & monitoring systems represented 14.2%. Accessories & other equipment accounted for 11.8% of the segment and continue to support day-to-day biobanking operations.
Cryogenic Storage Systems Segment is Projected to Register the Fastest Growth at a CAGR of 8.12%
The cryogenic storage systems segment is projected to register the fastest growth at a CAGR of 8.12% during 2026–2034. In 2025, the segment accounted for 39.8% of the temperature control systems segment, with a value of USD 35.96 billion. Growth is driven by increasing demand for long-term preservation of sensitive biological materials, growing stem cell research, and expanding requirements for reliable low-temperature biospecimen storage.
Freezers & refrigerators dominated the temperature control systems segment with a 46.5% share and a value of USD 42.01 billion. Thawing equipment accounted for 13.7%, with a value of USD 12.38 billion. These systems continue to support the preservation and controlled handling of biological samples across biobanking facilities.
Cold Chain Logistics Segment is Projected to Register the Fastest Growth at a CAGR of 9.24%
The cold chain logistics segment is projected to register the fastest growth at a CAGR of 9.24% during 2026–2034. In 2025, the segment accounted for 16.9% of the services segment, with a value of USD 15.27 billion. Growth is driven by increasing movement of temperature-sensitive biospecimens, rising demand for reliable sample transportation, and the need to maintain appropriate storage conditions throughout the logistics process.
Biobanking & repository services dominated the services segment with a 38.6% share and a value of USD 34.87 billion. Lab processing accounted for 23.4%, while qualification/validation represented 14.8%. Other services contributed 6.3% of the segment, supporting diverse operational requirements across biobanking facilities.
Stem Cells Segment is Projected to Register the Fastest Growth at a CAGR of 8.74%
The stem cells segment is projected to register the fastest growth at a CAGR of 8.74% during 2026–2034. In 2025, the segment accounted for 31.5% of the global biobanking market, with a value of USD 28.46 billion. Growth is driven by increasing stem cell research, expanding regenerative medicine activities, and rising demand for high-quality biological specimens for research and therapeutic development.
Human tissues dominated the market with a 36.7% share and a value of USD 33.15 billion. Other biospecimens accounted for 19.0%, while human organs represented 12.8%. Continued research into human diseases and biological processes supports demand for diverse biospecimen types.
IPS Cells Segment is Projected to Register the Fastest Growth at a CAGR of 10.18%
The IPS cells segment is projected to register the fastest growth at a CAGR of 10.18% during 2026–2034. In 2025, the segment accounted for 24.6% of the stem cells segment, with a value of USD 22.22 billion. Growth is driven by increasing research applications, growing interest in cellular models, and expanding use of induced pluripotent stem cells in biomedical research and therapeutic development.
Adult stem cells dominated the stem cells segment with a 46.2% share and a value of USD 41.74 billion. Embryonic stem cells accounted for 18.7%, while other stem cells represented 10.5%. These stem cell categories continue to support research and development activities across the life sciences sector.
Virtual Biobanks Segment is Projected to Register the Fastest Growth at a CAGR of 10.42%
The virtual biobanks segment is projected to register the fastest growth at a CAGR of 10.42% during 2026–2034. In 2025, the segment accounted for 17.4% of the global biobanking market, with a value of USD 15.72 billion. Growth is driven by increasing digitalization of biospecimen information, growing demand for remote access to biological sample data, and the integration of digital platforms for research collaboration and sample management.
Physical/real biobanks dominated the market with an 82.6% share and a value of USD 74.62 billion. Their leading position is supported by the need for physical collection, preservation, and management of biological samples. Increasing investments in biobanking infrastructure continue to support the segment.
Genetic (DNA/RNA) Segment is Projected to Register the Fastest Growth at a CAGR of 8.19%
The genetic (DNA/RNA) segment is projected to register the fastest growth at a CAGR of 8.19% during 2026–2034. In 2025, the segment accounted for 27.5% of the physical/real biobanks segment, with a value of USD 24.84 billion. Growth is driven by increasing genomic research, rising demand for molecular biospecimens, and expanding applications of DNA and RNA samples in precision medicine and biomedical research.
Tissue biobanks dominated the physical/real biobanks segment with a 34.8% share and a value of USD 31.44 billion. Genetic (DNA/RNA) biobanks accounted for 27.5%, while population-based biobanks represented 24.1%. Disease-based biobanks accounted for 13.6% and continue to support research focused on specific disease conditions.
Drug Discovery & Clinical Research Segment is Projected to Register the Fastest Growth at a CAGR of 8.68%
The drug discovery & clinical research segment is projected to register the fastest growth at a CAGR of 8.68% during 2026–2034. In 2025, the segment accounted for 39.6% of the global biobanking market, with a value of USD 35.77 billion. Growth is driven by increasing pharmaceutical and biotechnology research activities, rising demand for high-quality biospecimens, and the growing use of biological samples in drug development and clinical research.
The therapeutics segment accounted for 28.4% of the market, with a value of USD 25.66 billion and a CAGR of 8.25%. Clinical diagnostics represented 22.7% of the market, while other applications accounted for 9.3%. Increasing use of biospecimens across therapeutic research, diagnostics, and other biomedical applications continues to support market growth.
Speak to an Analystto discuss market opportunities.
Europe biobanking market accounted for 36.4% of the global market, reaching USD 32.88 billion in 2025, and is projected to grow at a CAGR of 7.45% during the forecast period. The market is driven by increasing biomedical research activities, growing demand for high-quality biological samples, expanding genomics and precision medicine research, and rising investments in biobanking infrastructure. Increasing collaborations between research institutions, healthcare organizations, and pharmaceutical companies continue to support regional market growth.
The UK market is supported by expanding biomedical research activities, increasing investments in biobank infrastructure, growing demand for biological samples, and rising adoption of advanced sample storage and management technologies.
Germany market growth is driven by strong pharmaceutical and biotechnology research, increasing demand for biological specimen collections, expanding precision medicine initiatives, and rising investments in advanced biobanking technologies.
Unlock Regional Insightsto access country-level data, & regional trends.
North America biobanking market accounted for 31.8% of the global market, reaching USD 28.73 billion in 2025, and is projected to grow at a CAGR of 7.12% during the forecast period. Increasing investments in biomedical research, growing adoption of genomics and personalized medicine, rising demand for high-quality biological samples, and expanding biobank networks continue to strengthen regional market growth. Technological advancements in sample preservation, data management, and automated storage further support market expansion.
The US market is supported by extensive biomedical research activities, increasing investments in genomics and precision medicine, growing pharmaceutical research, and rising adoption of automated sample storage and management systems.
Canada's market growth is driven by increasing investments in biomedical research, expanding population-based biobanks, growing demand for biological samples, and rising adoption of advanced specimen storage and data management technologies.
Asia Pacific biobanking market accounted for 21.6% of the global market, reaching USD 19.51 billion in 2025, and is projected to grow at a CAGR of 9.35% during the forecast period. Rapid expansion of healthcare and research infrastructure, increasing investments in genomics, growing pharmaceutical and biotechnology activities, and rising demand for biological samples continue to accelerate regional market growth. Increasing adoption of precision medicine and advanced biobanking technologies further strengthens market expansion.
China's market is supported by expanding biomedical research, increasing investments in genomics and biotechnology, growing demand for biological specimen collections, and rising development of large-scale biobanking infrastructure.
Japan's market growth is driven by increasing biomedical research, an aging population, growing demand for disease-specific biological samples, and rising investments in precision medicine and advanced biobanking technologies.
Middle East and Africa biobanking market accounted for 4.5% of the global market, totaling USD 4.07 billion in 2025, and is projected to grow at a CAGR of 6.41% during the forecast period. Increasing investments in healthcare and research infrastructure, growing biomedical research activities, expanding genomics initiatives, and rising demand for biological sample storage continue to support regional market growth.
The UAE market is supported by increasing investments in advanced healthcare and research infrastructure, growing genomics and precision medicine initiatives, expanding biomedical research capabilities, and rising adoption of modern biobanking technologies.
Africa's market growth is supported by expanding healthcare and research infrastructure, increasing investments in biomedical research, growing demand for biological sample collections, and rising focus on genomics and disease research, creating long-term opportunities for biobanking development across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Biologics Market Size, Share, Growth, Analysis, Report, 2034
Cell Surface Markers Detection Market Size, Share, Growth, 2034
Paper Diagnostics Market Size, Share, Growth, Forecast, 2034
Organ on Chip Market Size, Share, Growth, Analysis, 2034
Animal Model Market Size, Share, Growth, Analysis, Report, 2034
Capillary Electrophoresis Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com